This inventor holds 5 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Glaxo Group Limited, Smithkline Beecham Corporation. Active years: 2007-2012.
Company Filing History:
Years Active: 2007-2012
Title: Martin C Jones: Innovator in Quinoline Compounds
Introduction
Martin C Jones is a notable inventor based in Harlow, GB. He has made significant contributions to the field of chemistry, particularly in the development of quinoline compounds. With a total of 5 patents, his work has implications for various applications in medicinal chemistry.
Latest Patents
Jones's latest patents include innovative quinoline compounds that exhibit affinity for the 5-HT receptor. These compounds are defined by specific formulas where R, R, R, R, R, n, m, p, and A are detailed. His patents also cover the salts of these compounds, compositions containing them, and the processes for their production and use. Additionally, he has developed quinoline derivatives that serve as 5-HT6 ligands, further expanding the potential applications of his research.
Career Highlights
Throughout his career, Martin C Jones has worked with prominent companies in the pharmaceutical industry, including Glaxo Group Limited and SmithKline Beecham Corporation. His experience in these organizations has allowed him to refine his expertise and contribute to significant advancements in drug development.
Collaborations
Some of his notable coworkers include David Richard Witty and Mahmood Ahmed. Their collaborative efforts have likely enhanced the innovative outcomes of their projects.
Conclusion
Martin C Jones stands out as a key figure in the development of quinoline compounds, with a solid portfolio of patents that reflect his innovative spirit. His contributions continue to influence the field of medicinal chemistry and beyond.